Concepts (133)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Infections | 32 | 2024 | 4946 | 4.870 |
Why?
|
| Anti-HIV Agents | 16 | 2022 | 1275 | 4.260 |
Why?
|
| Counseling | 5 | 2024 | 136 | 2.480 |
Why?
|
| Time-to-Treatment | 3 | 2020 | 42 | 1.970 |
Why?
|
| Adult | 29 | 2024 | 5664 | 1.850 |
Why?
|
| South Africa | 32 | 2024 | 7312 | 1.840 |
Why?
|
| Anti-Retroviral Agents | 5 | 2021 | 542 | 1.740 |
Why?
|
| Infectious Disease Transmission, Vertical | 4 | 2022 | 467 | 1.660 |
Why?
|
| Female | 28 | 2024 | 8751 | 1.530 |
Why?
|
| Motivational Interviewing | 2 | 2022 | 10 | 1.520 |
Why?
|
| Humans | 36 | 2024 | 14077 | 1.500 |
Why?
|
| Pregnancy Complications, Infectious | 4 | 2022 | 507 | 1.450 |
Why?
|
| Male | 24 | 2024 | 6489 | 1.440 |
Why?
|
| Antiretroviral Therapy, Highly Active | 5 | 2021 | 468 | 1.350 |
Why?
|
| Prenatal Care | 3 | 2020 | 141 | 1.340 |
Why?
|
| Health Policy | 2 | 2021 | 132 | 1.320 |
Why?
|
| Attitude of Health Personnel | 2 | 2021 | 102 | 1.310 |
Why?
|
| Patient Compliance | 2 | 2022 | 120 | 1.300 |
Why?
|
| Continuity of Patient Care | 2 | 2021 | 33 | 1.290 |
Why?
|
| Patient Acceptance of Health Care | 3 | 2021 | 235 | 1.220 |
Why?
|
| Condoms | 3 | 2014 | 86 | 1.190 |
Why?
|
| Young Adult | 17 | 2021 | 2357 | 1.170 |
Why?
|
| Adolescent | 17 | 2022 | 2858 | 1.160 |
Why?
|
| Sexually Transmitted Diseases | 2 | 2020 | 101 | 1.060 |
Why?
|
| Qualitative Research | 3 | 2024 | 294 | 1.010 |
Why?
|
| Risk-Taking | 3 | 2016 | 119 | 1.010 |
Why?
|
| CD4 Lymphocyte Count | 6 | 2022 | 654 | 0.980 |
Why?
|
| Viral Load | 7 | 2022 | 808 | 0.970 |
Why?
|
| Sexual Partners | 4 | 2017 | 211 | 0.940 |
Why?
|
| Counselors | 1 | 2023 | 6 | 0.910 |
Why?
|
| Depressive Disorder, Major | 1 | 2023 | 20 | 0.900 |
Why?
|
| Middle Aged | 14 | 2021 | 3425 | 0.900 |
Why?
|
| Prospective Studies | 6 | 2021 | 1131 | 0.850 |
Why?
|
| Health Personnel | 2 | 2023 | 229 | 0.790 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 2 | 2018 | 34 | 0.780 |
Why?
|
| Lost to Follow-Up | 2 | 2022 | 62 | 0.770 |
Why?
|
| HIV-1 | 3 | 2019 | 1239 | 0.770 |
Why?
|
| Homosexuality, Male | 1 | 2021 | 48 | 0.750 |
Why?
|
| Cross-Sectional Studies | 8 | 2023 | 1377 | 0.740 |
Why?
|
| Motivation | 1 | 2021 | 56 | 0.740 |
Why?
|
| Pregnant Women | 2 | 2019 | 89 | 0.730 |
Why?
|
| Focus Groups | 4 | 2024 | 180 | 0.720 |
Why?
|
| Public-Private Sector Partnerships | 1 | 2019 | 16 | 0.690 |
Why?
|
| General Practice | 1 | 2019 | 5 | 0.690 |
Why?
|
| Primary Health Care | 4 | 2024 | 228 | 0.680 |
Why?
|
| Referral and Consultation | 1 | 2019 | 55 | 0.680 |
Why?
|
| Cohort Studies | 7 | 2022 | 939 | 0.650 |
Why?
|
| Depression, Postpartum | 1 | 2019 | 22 | 0.650 |
Why?
|
| Delivery of Health Care | 2 | 2021 | 230 | 0.650 |
Why?
|
| Socioeconomic Factors | 5 | 2021 | 405 | 0.630 |
Why?
|
| Sexual Behavior | 4 | 2021 | 313 | 0.620 |
Why?
|
| Patient Dropouts | 1 | 2017 | 18 | 0.590 |
Why?
|
| Obesity | 1 | 2020 | 356 | 0.580 |
Why?
|
| Maternal-Child Health Services | 1 | 2017 | 11 | 0.580 |
Why?
|
| Pregnancy | 5 | 2022 | 1815 | 0.560 |
Why?
|
| Drug Substitution | 1 | 2016 | 29 | 0.560 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 123 | 0.530 |
Why?
|
| Unsafe Sex | 2 | 2021 | 45 | 0.500 |
Why?
|
| Health Promotion | 1 | 2016 | 108 | 0.490 |
Why?
|
| Aged | 5 | 2021 | 1650 | 0.480 |
Why?
|
| Mass Screening | 1 | 2016 | 242 | 0.470 |
Why?
|
| Communication | 2 | 2024 | 56 | 0.450 |
Why?
|
| Time Factors | 3 | 2019 | 503 | 0.420 |
Why?
|
| Social Stigma | 2 | 2024 | 76 | 0.410 |
Why?
|
| Retrospective Studies | 3 | 2020 | 767 | 0.400 |
Why?
|
| Sex Work | 1 | 2012 | 39 | 0.390 |
Why?
|
| Safe Sex | 1 | 2011 | 67 | 0.380 |
Why?
|
| Policy | 2 | 2021 | 42 | 0.370 |
Why?
|
| Surveys and Questionnaires | 5 | 2021 | 532 | 0.350 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2021 | 247 | 0.350 |
Why?
|
| Proportional Hazards Models | 2 | 2020 | 163 | 0.340 |
Why?
|
| Postpartum Period | 2 | 2022 | 78 | 0.340 |
Why?
|
| Disclosure | 2 | 2021 | 25 | 0.330 |
Why?
|
| Self Report | 2 | 2021 | 111 | 0.320 |
Why?
|
| HIV Seropositivity | 1 | 2011 | 263 | 0.320 |
Why?
|
| Health Services Accessibility | 2 | 2021 | 265 | 0.300 |
Why?
|
| Medication Adherence | 2 | 2021 | 137 | 0.300 |
Why?
|
| Sex Factors | 2 | 2021 | 224 | 0.290 |
Why?
|
| Follow-Up Studies | 2 | 2018 | 367 | 0.280 |
Why?
|
| Age Factors | 2 | 2021 | 364 | 0.280 |
Why?
|
| Risk Factors | 3 | 2019 | 1431 | 0.280 |
Why?
|
| Prevalence | 4 | 2019 | 1149 | 0.250 |
Why?
|
| Logistic Models | 2 | 2019 | 252 | 0.250 |
Why?
|
| Needs Assessment | 1 | 2024 | 29 | 0.230 |
Why?
|
| Incidence | 3 | 2020 | 655 | 0.210 |
Why?
|
| Information Dissemination | 1 | 2021 | 7 | 0.200 |
Why?
|
| Standard of Care | 1 | 2022 | 28 | 0.200 |
Why?
|
| Disease Transmission, Infectious | 1 | 2021 | 39 | 0.200 |
Why?
|
| Universities | 1 | 2021 | 34 | 0.190 |
Why?
|
| Students | 1 | 2021 | 48 | 0.190 |
Why?
|
| Urban Population | 2 | 2014 | 246 | 0.190 |
Why?
|
| Health Facilities | 1 | 2021 | 39 | 0.190 |
Why?
|
| Text Messaging | 1 | 2021 | 25 | 0.180 |
Why?
|
| Child | 3 | 2022 | 2180 | 0.180 |
Why?
|
| Sex Distribution | 1 | 2020 | 89 | 0.180 |
Why?
|
| Drug Administration Schedule | 2 | 2017 | 153 | 0.180 |
Why?
|
| Health Status | 1 | 2021 | 111 | 0.180 |
Why?
|
| Interviews as Topic | 1 | 2021 | 190 | 0.180 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 243 | 0.180 |
Why?
|
| Physician-Patient Relations | 1 | 2019 | 14 | 0.170 |
Why?
|
| Program Evaluation | 1 | 2019 | 89 | 0.170 |
Why?
|
| Health Resources | 1 | 2019 | 65 | 0.170 |
Why?
|
| Ambulatory Care Facilities | 1 | 2019 | 125 | 0.160 |
Why?
|
| Social Support | 1 | 2019 | 76 | 0.160 |
Why?
|
| Infant | 2 | 2022 | 2145 | 0.150 |
Why?
|
| Quality of Life | 1 | 2019 | 170 | 0.150 |
Why?
|
| Treatment Failure | 1 | 2017 | 175 | 0.140 |
Why?
|
| Pregnancy Outcome | 1 | 2017 | 112 | 0.140 |
Why?
|
| Risk Assessment | 1 | 2017 | 217 | 0.130 |
Why?
|
| Depression | 1 | 2017 | 117 | 0.130 |
Why?
|
| Case-Control Studies | 1 | 2017 | 464 | 0.130 |
Why?
|
| Drug Resistance, Viral | 1 | 2017 | 268 | 0.130 |
Why?
|
| Cultural Characteristics | 1 | 2014 | 15 | 0.120 |
Why?
|
| Attitude to Health | 1 | 2014 | 56 | 0.120 |
Why?
|
| Circumcision, Male | 1 | 2014 | 97 | 0.110 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 449 | 0.100 |
Why?
|
| Rural Population | 1 | 2014 | 624 | 0.090 |
Why?
|
| RNA | 1 | 2022 | 26 | 0.050 |
Why?
|
| Diffusion of Innovation | 1 | 2021 | 10 | 0.050 |
Why?
|
| Africa, Southern | 1 | 2022 | 89 | 0.050 |
Why?
|
| National Health Programs | 1 | 2022 | 78 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 210 | 0.040 |
Why?
|
| HIV | 1 | 2022 | 380 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2021 | 867 | 0.040 |
Why?
|
| Comorbidity | 1 | 2017 | 184 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2017 | 235 | 0.030 |
Why?
|
| Developing Countries | 1 | 2018 | 385 | 0.030 |
Why?
|
| Models, Theoretical | 1 | 2015 | 78 | 0.030 |
Why?
|
| Algorithms | 1 | 2015 | 105 | 0.030 |
Why?
|
| Population Surveillance | 1 | 2016 | 325 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 171 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2016 | 1410 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2016 | 1675 | 0.020 |
Why?
|